BioAffinity Technologies Inc (NASDAQ:BIAF) has a beta value of 2.52 and has seen 0.42 million shares traded in the recent trading session. The company, currently valued at $8.49M, closed the recent trade at $0.3 per share which meant it lost -$0.01 on the day or -2.74% during that session. The BIAF stock price is -896.67% off its 52-week high price of $2.99 and 46.67% above the 52-week low of $0.16. If we look at the company’s 10-day average daily trading volume, we find that it stood at 2.5 million shares traded. The 3-month trading volume is 7.04 million shares.
BioAffinity Technologies Inc (NASDAQ:BIAF) trade information
Sporting -2.74% in the red today, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the BIAF stock price touched $0.3 or saw a rise of 13.94%. Year-to-date, BioAffinity Technologies Inc shares have moved -88.06%, while the 5-day performance has seen it change 1.81%. Over the past 30 days, the shares of BioAffinity Technologies Inc (NASDAQ:BIAF) have changed 1.39%. Short interest in the company has seen 0.77 million shares shorted with days to cover at 0.1.
BioAffinity Technologies Inc (BIAF) estimates and forecasts
The company’s shares have lost -67.60% over the past 6 months. Revenue growth from the last financial year stood is estimated to be -30.57%.
1 analysts offering their estimates for the company have set an average revenue estimate of 1.51M for the current quarter. 1 have an estimated revenue figure of 1.55M for the next ending quarter. Year-ago sales stood 2.4M and 2.35M respectively for this quarter and the next, and analysts expect sales will shrink by -37.19% for the current quarter and -30.57% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -10.71% over the past 5 years.
BIAF Dividends
BioAffinity Technologies Inc is expected to release its next earnings report on 2025-May-15 this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
BioAffinity Technologies Inc (NASDAQ:BIAF)’s Major holders
Insiders own 24.52% of the company shares, while shares held by institutions stand at 1.80% with a share float percentage of 2.38%. Investors are also buoyed by the number of investors in a company, with BioAffinity Technologies Inc having a total of 17.0 institutions that hold shares in the company. The top two institutional holders are VANGUARD GROUP INC with over 0.17 million shares worth more than $0.37 million. As of 2024-06-30, VANGUARD GROUP INC held 1.5101% of shares outstanding.
The other major institutional holder is GEODE CAPITAL MANAGEMENT, LLC, with the holding of over 69600.0 shares as of 2024-06-30. The firm’s total holdings are worth over $0.15 million and represent 0.6111% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and Fidelity Concord Street Trust-Fidelity Extended Market Index Fund . As of Mar 31, 2025 , the former fund manager holds about 0.48% shares in the company for having 136.25 shares of worth $39377.0 while later fund manager owns 68.81 shares of worth $19886.0 as of May 31, 2025 , which makes it owner of about 0.24% of company’s outstanding stock.
